Radioisotopic localization of (90)Yttrium-ibritumomab tiuxetan in patients with CD20+ non-Hodgkin's lymphoma.

Jacobs, S A; Harrison, A M; Swerdlow, S H; Foon, K A; Avril, N; Vidnovic, N; Joyce, J; DeMonaco, N; McCarty, K S

Jacobs, S A; Harrison, A M; Swerdlow, S H; Foon, K A; Avril, N; Vidnovic, N; Joyce, J; DeMonaco, N; McCarty, K S.

Affiliation

Jacobs SA; University of Pittsburgh Medical Center, University of Pittsburgh Cancer Institute and UPMC Cancer Centers, PA 15232, USA. jacobssa@upmc.edu

Mol Imaging Biol ; 11(1): 39-45, 2009.

Article in En | MEDLINE | ID: mdl-18773247

Subject(s)

Antibodies, Monoclonal/therapeutic use; Lymphoma, Non-Hodgkin/radiotherapy; Radioimmunotherapy/methods; Yttrium Radioisotopes/therapeutic use; Aged; Aged, 80 and over; Antibodies, Monoclonal/adverse effects; Antigens, CD20/immunology; Autoradiography; Humans; Leukemia, Lymphocytic, Chronic, B-Cell/radiotherapy; Lymphoma, Follicular/radiotherapy; Lymphoma, Large B-Cell, Diffuse/radiotherapy; Lymphoma, Mantle-Cell/radiotherapy; Lymphoma, Non-Hodgkin/pathology; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Yttrium Radioisotopes / Lymphoma, Non-Hodgkin / Radioimmunotherapy / Antibodies, Monoclonal Limits: Aged / Aged80 / Humans / Middle aged Language: En Journal: Mol Imaging Biol Journal subject: BIOLOGIA MOLECULAR / DIAGNOSTICO POR IMAGEM Year: 2009 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google